Aller au contenu principal
Accès ouvert déclaré 2026 review

Risk prediction rules in individuals at risk of rheumatoid arthritis: systematic review and validation using the APIPPRA cohort

0Citations signalées — pas une note de qualité
6Institutions déclarées
1Pays d’affiliation déclarés

Résumé fourni par la source

Objectives: To review risk prediction rules (RPRs) in individuals at risk of rheumatoid arthritis (RA) and to externally validate them using an independent interception trial cohort. Methods: We performed a systematic literature search of MEDLINE and EMBASE on November 30, 2023, updated on July 10, 2025, to identify studies reporting RA RPRs in individuals at risk of RA. Each RPR was assessed across 4 Prediction Model Risk of Bias Assessment Tool domains: participants, predictors, outcome, and analysis. Eligible RPRs were externally validated by examining risk score distributions by RA progression, and evaluating discrimination, predictive accuracy and calibration. Results: We identified 25 studies describing 41 RPRs in at-risk individuals. Rules incorporating clinical and serological prognostic factors, with or without imaging, were most common. Internal validation was reported in 23 (56%) RPRs and external validation in only 4 (9%). The discrimination C-statistic ranged from 0.59 to 0.98 during development and was presented as the sole performance measure in 21 (51%) RPRs. External validation of 14 RPRs revealed 4 (29%) with moderate discrimination (C-statistic, 0.6-0.7) and 10 (71%) with poor discrimination (C-statistic, <0.6). Brier scores ranged from 0.20 to 0.24 for 6 RPRs, indicating relatively better overall accuracy, whereas 7 RPRs had poorer overall fit (Brier score ≥0.25). Calibration plots showed reasonable calibration in 2 RPRs, with most demonstrating systematic or partial miscalibration. Conclusions: Existing RA RPRs demonstrated inconsistent performance when externally validated, underscoring population heterogeneity and the need for robust model development, transparent reporting, and independent external validation before clinical implementation.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Risk prediction rules in individuals at risk of rheumatoid arthritis: systematic review and validation using the APIPPRA cohort
Date Crossref
01/09/2026
Éditeur
Elsevier BV
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Rheumatoid Arthritis Research and TherapiesStatistical Methods in EpidemiologyReliability and Agreement in Measurement

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.